Cardiology update 2017: The first quarter
In the first quarter of 2017, proprotein convertase subtilisin/kexin type 9's role got defined further with a number of trials such as FOURIER, ORION-1, and SPIRE 1 and 2. TAVI proves safe in intermediate-risk patients in the Surgical Replacement and Transcatheter Aortic Valve Implantation stud...
| 發表在: | Journal of the Practice of Cardiovascular Sciences |
|---|---|
| 主要作者: | |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Wolters Kluwer Medknow Publications
2017-01-01
|
| 主題: | |
| 在線閱讀: | http://www.j-pcs.org/article.asp?issn=2395-5414;year=2017;volume=3;issue=1;spage=18;epage=21;aulast=Umapathy |